Equities

Lotus Eye Hospital and Institute Ltd

LOTUSEYE:NSI

Lotus Eye Hospital and Institute Ltd

Actions
Health CareHealth Care Providers
  • Price (INR)62.35
  • Today's Change0.00 / 0.00%
  • Shares traded51.92k
  • 1 Year change+0.08%
  • Beta0.3943
Data delayed at least 15 minutes, as of Apr 30 2024 11:02 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Lotus Eye Hospital and Institute Limited is an India-based company, which is engaged in the business of healthcare activities. The Company operates primarily in the field of ophthalmology (Eye) and its related operations. It resolves a range of eye problems, such as refractive, cataract, cornea infections, ocular prosthesis, orbit and oculoplasty, glaucoma, keratoconus, computer vision syndrome, neuro ophthalmology, retinal disease/diabetic eye care, UVEA and ocular inflammation, zyoptix-ultimate, and binocular vision. The Company provides treatments through ReLEx SMILE, Lasik Eye Surgery, Epi-LASIK, Intralase, Supracor, Robotic Femto Laser Cataract Surgery (LRCS), Phacoemulsification, Paediatric Eye Care and Squint Surgery, and Micro Incision Cataract Surgery (MICS). The Company operates approximately seven centers at Peelamedu, R.S. Puram, Mettupalayam, Tirupur, Salem, Cochin, and Mulanthurthy.

  • Revenue in INR (TTM)484.95m
  • Net income in INR35.38m
  • Incorporated1997
  • Employees209.00
  • Location
    Lotus Eye Hospital and Institute Ltd770/12 Avinashi Road, Civil Aerodrome post,COIMBATORE 641014IndiaIND
  • Phone+91 4 224229999
  • Fax+91 4 222627193
  • Websitehttps://www.lotuseye.org/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Aatmaj Healthcare Ltd-100.00bn-100.00bn844.11m----7.66----------4.88------------------------1.59--0.4478--24.55--20.03------
Maitreya Medicare Ltd-100.00bn-100.00bn1.20bn----7.07----------24.97------------------------2.01--0.225---20.30--271.95------
Lotus Eye Hospital and Institute Ltd484.95m35.38m1.30bn209.0036.44--18.732.671.711.7123.45------------3.51--3.8952.3653.567.305.27--44.46----20.904.3536.6318.48-6.250.00
QMS Medical Allied Services Ltd-100.00bn-100.00bn1.92bn51.00--2.57----------41.75----------14.62--36.19--21.53--7.521.33--0.30780.00-28.90315.81-40.42296.61----
Data as of Apr 30 2024. Currency figures normalised to Lotus Eye Hospital and Institute Ltd's reporting currency: Indian Rupee INR
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.